Boğaziçi University Center for Targeted Therapy Technologies (CT3), founded on the basis of the Boğaziçi University Life Sciences and Technologies Application and Research Center (LifeSci) which established in 2010, integrates experts from 13 departments to conduct interdisciplinary research in life sciences, health, and biotechnology. With advanced infrastructure, the center pioneers innovative technologies, including cancer diagnostics, drug delivery systems, and biosensing platforms. CT3 is the new center established with Ministry support for LifeSci, which has completed over 100 projects, published 1,200 high-impact papers, and holds 13 international patents. Supported by national and EU funds, CT3 aims to accelerate innovations that benefit both the Turkish economy and global health through collaboration between academia and industry.

Founded in 2010, Erzurum Technical University, with its young and dynamic structure, plays a leading role in education, research, and innovative projects. It offers undergraduate and graduate programs in science, engineering, and health sciences, providing students with an education at international standards. With its modern laboratories, strong academic staff, and research-focused approach, our university stands out for its scientific productivity, technological development capacity, and social contribution. Erzurum Technical University aims to add value to science and humanity through national and international collaborations.

The institution, with its modern research infrastructure and strong academic staff, aims to train experts in education, health, and industry at international standards. Guided by scientific and ethical values, it places interdisciplinary collaboration at its core and pioneers innovative studies, developing projects that shape the future of our country. Its mission is to lead progress under all circumstances and provide services that add value to society. Its vision is to become a pioneering institution on an international scale with comprehensive infrastructure and a distinguished educational approach, directing scientific and technological advances in nanotechnology and biotechnology.

T.R. No. 29290, dated 9 March 2015, accepted by the Turkish Grand National Assembly on 16/02/2015. With the decision number 2015/7321 published in the Official Gazette, it was decided to change the name of the Hemodialysis-Transplantation Institute within the Rectorate of Dokuz Eylül University to Izmir International Biomedicine and Genome Institute, and our institute started its educational activities. The first student recruitment to our institute was made in the 2016-2017 academic year. The Department of Genomic Sciences and Biotechnology was established within our institute and started its educational activities. Master's and PhD students study in this department. There are 1 associate professor and 3 doctor faculty members in the institute staff within the department. These faculty members carry out our academic activities by assigning them from other academic units of our university. Our Biomedicine and Health Technologies department, which was opened at the establishment of our institute, has not started its educational activities yet. He started teaching with the Molecular Biology and Genetics Master's and Doctoral Programs affiliated with the Department of Genome Sciences and Molecular Biotechnology at the Izmir International Biomedicine and Genome Institute, which was established on 16/02/2015. With the senate decision numbered 439 meeting dated 07/04/2015 and the YÖK Board decision dated 28/04/2015, the "Department of Genomic Sciences and Molecular Biotechnology" and the "Department of Biomedicine and Health Technologies" were established. In its initial establishment phase, our institute operated within the Izmir Biomedicine and Genome Center until February 2018, and after this date, the center and the institute continue their activities separately. Our university rector, Prof., during the establishment phase of our institute. Dr. Mehmet Füzün, our founding director Prof.Dr. It was opened with the participation of Mehmet Öztürk, Minister of Science, Industry and Technology Fikri Işık, Izmir Governor Mustafa Toprak, Nobel Prize winner Sir Tim Hunt, as well as many local and foreign scientists. Our institute started its activities in the same building with the Izmir Biomedicine and Genome Center during its initial establishment phase and currently continues its activities in the same building.

Health Sciences University Technology Developmnet Zone Health Technopole Inc. - Teknopol İstanbul was established on March 23, 2018, as a pioneering technopark in the field of health technologies in Turkey. With a strong partnership structure that includes Health Sciences University, Teknopolis TTO Inc., Vakıf Yatırım, Boğaziçi University, Tuzla Municipality, and Pendik Municipality, it hosts R&D and innovation-oriented projects in the field of health technologies. In addition, Teknopol İstanbul aims to include, in the upcoming period, organizations operating in various fields such as health, medical technologies, software, food industry, banking and finance, domestic pharmaceutical production, medical design and patent services, as well as traditional medicine studies.

Our company, operating within Trakya Technopark in the pharmaceutical, cosmetics, chemical raw materials manufacturing, and R&D consultancy sectors, aims to deliver accessible products at low cost by creating formulations with clean ingredients sourced from sustainable resources. We strive to make a difference in the industry and add value through innovation. Additionally, we develop projects that contribute to regional value, such as research on Edirne Red and Edirne Rose, and pursue innovative concepts like edible perfumes. Areas of Expertise: Pharmacy Cosmetics Nanotechnology